Regulation of the hepatitis C virus genome replication by miR-199a.

[1]  B. Cullen,et al.  MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs , 2008, Nature.

[2]  Zhenyu Xuan,et al.  A biochemical approach to identifying microRNA targets , 2007, Proceedings of the National Academy of Sciences.

[3]  Chris Sander,et al.  Cellular cofactors affecting hepatitis C virus infection and replication , 2007, Proceedings of the National Academy of Sciences.

[4]  M. Hentze,et al.  Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. , 2007, Journal of hepatology.

[5]  Hsien-Da Huang,et al.  ViTa: prediction of host microRNAs targets on viruses , 2006, Nucleic Acids Res..

[6]  Hussein H. Aly,et al.  Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. , 2007, Journal of hepatology.

[7]  B. Scholte,et al.  Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  B. Cullen.  Viruses and microRNAs , 2006, Nature Genetics.

[9]  N. Kato,et al.  Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication , 2006, Journal of Virology.

[10]  T. Okanoue,et al.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.

[11]  N. Kato,et al.  Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. , 2006, Gastroenterology.

[12]  R. Pillai.  MicroRNA function: multiple mechanisms for a tiny RNA? , 2005, RNA.

[13]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[14]  Phillip D. Zamore,et al.  Ribo-gnome: The Big World of Small RNAs , 2005, Science.

[15]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[16]  B. Rehermann,et al.  Immunology of hepatitis B virus and hepatitis C virus infection , 2005, Nature Reviews Immunology.

[17]  T. Ohshima,et al.  Suppression of hepatitis C virus replicon by TGF-beta. , 2005, Virology.

[18]  G. Foster.  Past, present, and future hepatitis C treatments. , 2004, Seminars in liver disease.

[19]  T. Ohshima,et al.  Transforming Growth Factor-β-mediated Signaling via the p38 MAP Kinase Pathway Activates Smad-dependent Transcription through SUMO-1 Modification of Smad4* , 2003, Journal of Biological Chemistry.

[20]  K. Shimotohno,et al.  Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes , 2003, Hepatology.

[21]  C. Mamotte,et al.  Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection , 2003, Journal of medical virology.

[22]  Mamoru Watanabe,et al.  Inhibition of intracellular hepatitis C virus replication by synthetic and vector‐derived small interfering RNAs , 2003, EMBO reports.

[23]  F. Chisari,et al.  Interference of hepatitis C virus RNA replication by short interfering RNAs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[25]  長沼 篤.  Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein , 2001 .

[26]  N. Kato,et al.  Activation of the Interferon-Inducible 2′-5′-Oligoadenylate Synthetase Gene by Hepatitis C Virus Core Protein , 2000, Journal of Virology.

[27]  M. Alter,et al.  Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.

[28]  M. Kohara,et al.  Hepatitis C virus structural proteins induce liver cell injury in transgenic mice , 1999, Journal of medical virology.

[29]  William M. Lee,et al.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.

[30]  S. Hirohashi,et al.  Replication of Hepatitis C Virus in Cultured Non‐neoplastic Human Hepatocytes , 1996, Japanese journal of cancer research : Gann.